Korea’s leading drugmakers hit by sluggish sales

Influenced by anti-rebate sales policies, domestic leading pharmaceutical firms, Dong-A Pharm, Hanmi Pharm, Daewoong Pharm and Yuhan Corp., saw their monthly sales plunge, according to pharmaceutical business sources.

So far, large pharmaceutical companies have endeavored to refrain from using rebates as a marketing tool. While drug companies heeded the Health Ministry’s threat to slash the ...